| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |